Volume 175 Issue 5

Editorials

• Vitamin D deficiency and multicultural Australia Rebecca S Mason, Terrence H Diamond (MJA 2001; 175: 236-237)
• Evolving evidence and continuing uncertainties for eating disorders David I Ben-Tovim, Peter N Gilchrist, M Kay Walker (MJA 2001; 175: 238-239)
• Preventing osteoporosis naturally N Kathryn Henderson, Richard L Prince (MJA 2001; 175: 239-240)
• Trials on trial Martin B Van Der Weyden (MJA 2001; 175: 241)

Research

• An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss David B Cleghorn, Peter D O'Loughlin, B June Schroeder, B E Christopher Nordin (MJA 2001; 175: 242-245)
• High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening? Chris J Hovell, Judith A Collett, Guy Vautier, Andy J P Cheng, Erica Sutanto, Dominic F Mallon, John K Olynyk, Digby J E Cullen (MJA 2001; 175: 247-250)

Medicine and the Community

• Vitamin D deficiency in veiled or dark-skinned pregnant women Sonia R Grover, Ruth Morley (MJA 2001; 175: 251-252)
• Vitamin D deficiency in mothers of infants with rickets Josephine M Nozza, Christine P Rodda (MJA 2001; 175: 253-255)

Diagnostic Dilemmas

• Contaminated medication precipitating hypoglycaemia Adrian M Goudie, Joey M Kaye (MJA 2001; 175: 256-257)

Position Statement

• Anticoagulation in pregnancy and the puerperium A Working Group on behalf of the Obstetric Medicine Group of Australasia (MJA 2001; 175: 258-263)

Systematic Review

• Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis Michael Whitby, Mary-Louise McLaws, Geoffrey Berry (MJA 2001; 175: 264-267)

Viewpoint

• Not-so-simple Simon Ken R Cox (MJA 2001; 175: 268-269)

Lessons from Practice

• Hydrofluoric acid burn from a household rust remover Sandra M Mangion, Suzanne H Beulke, George Braitberg (MJA 2001; 175: 270-271)

EBM: Trials on Trial

• Randomised controlled trials: elements of a good study Val J Gebski, Elaine M Beller, Anthony C Keech (MJA 2001; 175: 272-274)
• Can ACE inhibitor therapy prevent end-stage renal failure? Jonathan C Craig (MJA 2001; 175: 276)

MJA Practice Essentials — Neurology

• Cancer and the nervous system Lawrence M Cher (MJA 2001; 175: 277-282)